Cytotoxic T cell (CD8+ T lymphocyte)
A cytotoxic T cell is a type of T lymphocyte that recognizes peptide antigens on MHC I and kills infected, malignant, or damaged cells via targeted cytotoxic mechanisms.
Overview
A cytotoxic T cell is a specialized type of white blood cell responsible for directly killing host cells that are infected, transformed, or otherwise abnormal. Often called CD8+ T cells, these lymphocytes patrol the body and use a specific T-cell receptor to detect short peptide fragments displayed on the surface of other cells. When a match is found the cytotoxic T cell initiates a targeted response that eliminates the compromised cell and helps limit spread of infection or malignancy. See general categories: white blood cell, T lymphocyte, cancer cells, viruses.
Image gallery
3 ImagesRecognition and activation
Cytotoxic T cells detect antigenic peptides that originate inside a cell and are presented on major histocompatibility complex class I molecules. The peptide–MHC I complex is the critical target for the T-cell receptor and co-receptor interactions. Antigenic peptide and MHC presentation are central concepts: antigen presentation and major histocompatibility complex. Activation of a naive cytotoxic T cell typically requires antigen presentation by a professional antigen-presenting cell, co-stimulatory signals, and supportive cytokines; successful activation leads to clonal expansion and differentiation into effector and memory cells.
Effector mechanisms
Cytotoxic T cells employ several focused mechanisms to kill target cells and to shape the immune response. Major mechanisms include:
- Perforin and granzymes: release of pore-forming proteins and proteases that trigger apoptosis in the target.
- Fas–FasL interaction: engagement of death receptors that initiates programmed cell death.
- Cytokine secretion: interferon-gamma and tumor necrosis factor help control infections and modulate surrounding immune cells.
Roles and clinical importance
These cells are essential for controlling intracellular pathogens and for tumor surveillance. They contribute to outcomes in viral infections, certain cancers, transplant rejection, and some autoimmune conditions when regulation fails. Clinically, cytotoxic T cells are harnessed in therapies such as adoptive T-cell transfer and engineered chimeric antigen receptor (CAR) T-cell treatments; vaccines aim to elicit effective cytotoxic responses against pathogens and tumors.
Distinctions and notable facts
Although most cytotoxic T cells express CD8 and recognize peptides on MHC I, other cytotoxic lymphocytes—such as natural killer cells—can kill without antigen-specific T-cell receptors. Rare CD4+ T cells can also acquire cytotoxic activity in particular contexts. The balance between effective cytotoxic responses and tolerance is critical: insufficient activity permits infection or cancer progression, while excessive or misdirected activity can cause tissue damage.
Related articles
Author
AlegsaOnline.com Cytotoxic T cell (CD8+ T lymphocyte) Leandro Alegsa
URL: https://en.alegsaonline.com/art/24967